Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Shift Labs announces Dave Anderson as Chief Executive Officer
  • USA - English

Shift Labs' new CEO appointment supports the Company's focus on strategic and long-term initiatives to build on record 2020 growth.


News provided by

Shift Labs, Inc.

Apr 07, 2021, 11:00 ET

Share this article

Share toX

Share this article

Share toX

SEATTLE, April 7, 2021 /PRNewswire-PRWeb/ -- Shift Labs is excited to announce it has entered into a new strategic expansion phase, naming Dave Anderson as President and Chief Executive Officer to lead this growth. In his role, Dave will assume day-to-day leadership of the Company and will also join Shift Labs' Board of Directors. Dave is an experienced strategist and leader whose past experience will play a crucial role in the growing importance of digital health strategy for Shift Labs' DripAssist Infusion Rate Monitor line of products, now in distribution globally and later this year to expand to include new software solutions for infusion monitoring. He will lead the Company's efforts to capitalize on new geographic expansion and digital health offerings, as well as strengthen existing distribution partnerships.

"I am excited to lead Shift Labs through our next phase of strategic growth and development. As the needs for home and alternate site infusion care continue to rise, the Company is uniquely positioned to revolutionize infusion delivery and improve the accuracy of IV medication administration," said Anderson. "I am honored to be joining this incredible team and continuing to bring new innovations to market that improve the health and wellness of patients everywhere."

As a thought leader with over 25 years' experience leading the development and commercialization of enterprise technology solutions in healthcare and data analytics, Dave is in a position to accelerate Shift Labs' transformation of the infusion industry by introducing best-in-class, affordable infusion solutions that leverage the rapid growth in out-of-hospital-care driven jointly by post-COVID treatment trends and healthcare economics.

According to Anderson, "The explosive growth in telemedicine and at-home care driven by COVID demands better drug delivery solutions for the home, and DripAssist products will play a pivotal role in meeting this critical need."

In 2020, Shift Labs launched a commercialization partnership for the Americas and accelerated work on DripAssist Connect, a Bluetooth-enabled infusion monitor keenly anticipated by clinicians and clinical research organizations to integrate gravity infusion data into electronic health records. COVID pressure on healthcare systems in 2020 resulted in an increasing reliance on gravity infusion. The increased control and accuracy that the Company's DripAssist product provides to any gravity infusion allowed the company to support this increased demand and double in revenue as a result. 2021 promises to be another year of record growth for the Company as its connected device comes online in multiple markets and delivers ground-breaking insights into IV drug delivery in acute and non-acute care settings.

Outgoing CEO and Shift Labs co-founder Beth Kolko will move into the Board Chair role. According to Kolko, "Shift Labs is incredibly lucky to have Dave at the helm to drive the next phase of company growth. We're confident it's time for a revolution in infusion delivery, and his strategic vision will allow us to capitalize on the global potential for DripAssist products."

Prior to joining Shift Labs, Dave was President and CEO at MD Kinect, Inc., a leading digital health patient management company. Dave has held senior positions at both Fortune 250 companies and several Silicon Valley startups, including Founder and CEO of a performance management analytics company. Dave holds an MBA from Duke University.

About Shift Labs
Shift Labs, Inc. is a Seattle-based company that creates best-in-class designed medical devices for fast-growing healthcare sectors, from alternative site care in the US to clinical care in emerging markets. The DripAssist Infusion Rate Monitor has previously been recognized as one of Popular Science Magazine's 12 Best Healthcare Innovations of 2016, as well as receiving the MedTech Conference's 2017 Global Health Innovation Award, a Silver medal from the Industrial Designers Society of America IDEA awards, funding from USAID as part of the Ebola Grand Challenge and Saving Lives at Birth: A Grand Challenge for Development, and a Phase II SBIR contract from the US Air Force. Learn more at http://www.shiftlabs.com.

Inquiries:
Contact Dave Anderson, CEO, at [email protected], or Koji Intlekofer, CTO, at [email protected], or call +1 206.369.1216.

Media Contact

Dave Anderson, CEO, Shift Labs, Inc., +1 2063691216, [email protected]

Koji Intlekofer, CTO, Shift Labs, Inc., [email protected]

Twitter

SOURCE Shift Labs, Inc.

Related Links

http://www.shiftlabs.com

Modal title

Press Release PDF
View PDF
Press Release PDF
Press Release PDF

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.